JPMorgan Chase & Co. Begins Coverage on Livongo Health (NASDAQ:LVGO)

JPMorgan Chase & Co. assumed coverage on shares of Livongo Health (NASDAQ:LVGO) in a research note published on Monday morning, BenzingaRatingsTable reports. The brokerage issued an overweight rating and a $43.00 price target on the stock.

Several other equities analysts have also issued reports on the company. Leerink Swann initiated coverage on Livongo Health in a report on Monday. They set an outperform rating and a $50.00 price objective on the stock. KeyCorp initiated coverage on Livongo Health in a report on Monday. They set an overweight rating and a $46.00 price objective on the stock. Needham & Company LLC initiated coverage on Livongo Health in a report on Monday. They set a buy rating and a $42.00 price objective on the stock. Piper Jaffray Companies initiated coverage on Livongo Health in a report on Monday. They set an overweight rating and a $40.00 price objective on the stock. Finally, Chardan Capital initiated coverage on Livongo Health in a report on Friday, August 16th. They set a neutral rating and a $40.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average price target of $44.20.

Shares of LVGO stock opened at $34.95 on Monday. Livongo Health has a 1 year low of $31.60 and a 1 year high of $45.68.



In other news, Director Hemant Taneja acquired 2,678,571 shares of Livongo Health stock in a transaction that occurred on Monday, July 29th. The stock was purchased at an average price of $28.00 per share, for a total transaction of $74,999,988.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of Livongo Health stock in a transaction that occurred on Monday, July 29th. The stock was purchased at an average price of $28.00 per share, with a total value of $87,970,260.00. The disclosure for this purchase can be found here.

Livongo Health Company Profile

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Recommended Story: Why do companies issue convertible shares?

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.